These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35317607)

  • 1. Gene Therapy With the N-Terminus of Junctophilin-2 Improves Heart Failure in Mice.
    Wang J; Shi Q; Wang Y; Dawson LW; Ciampa G; Zhao W; Zhang G; Chen B; Weiss RM; Grueter CE; Hall DD; Song LS
    Circ Res; 2022 Apr; 130(9):1306-1317. PubMed ID: 35317607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing Site-Specific Calpain Proteolysis of Junctophilin-2 Protects Against Stress-Induced Excitation-Contraction Uncoupling and Heart Failure Development.
    Wang J; Chen B; Shi Q; Ciampa G; Zhao W; Zhang G; Weiss RM; Peng T; Hall DD; Song LS
    Circulation; 2024 Sep; ():. PubMed ID: 39291390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E-C coupling structural protein junctophilin-2 encodes a stress-adaptive transcription regulator.
    Guo A; Wang Y; Chen B; Wang Y; Yuan J; Zhang L; Hall D; Wu J; Shi Y; Zhu Q; Chen C; Thiel WH; Zhan X; Weiss RM; Zhan F; Musselman CA; Pufall M; Zhu W; Au KF; Hong J; Anderson ME; Grueter CE; Song LS
    Science; 2018 Dec; 362(6421):. PubMed ID: 30409805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AAV-9 mediated phosphatase-1 inhibitor-1 overexpression improves cardiac contractility in unchallenged mice but is deleterious in pressure-overload.
    Schwab DM; Tilemann L; Bauer R; Heckmann M; Jungmann A; Wagner M; Burgis J; Vettel C; Katus HA; El-Armouche A; Müller OJ
    Gene Ther; 2018 Jan; 25(1):13-19. PubMed ID: 29350681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
    Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
    Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytosolic DNA sensor cGAS plays an essential pathogenetic role in pressure overload-induced heart failure.
    Hu D; Cui YX; Wu MY; Li L; Su LN; Lian Z; Chen H
    Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1525-H1537. PubMed ID: 32383996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablation of cardiac TIGAR preserves myocardial energetics and cardiac function in the pressure overload heart failure model.
    Okawa Y; Hoshino A; Ariyoshi M; Kaimoto S; Tateishi S; Ono K; Uchihashi M; Iwai-Kanai E; Matoba S
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1366-H1377. PubMed ID: 30901275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microtubule-mediated defects in junctophilin-2 trafficking contribute to myocyte transverse-tubule remodeling and Ca2+ handling dysfunction in heart failure.
    Zhang C; Chen B; Guo A; Zhu Y; Miller JD; Gao S; Yuan C; Kutschke W; Zimmerman K; Weiss RM; Wehrens XH; Hong J; Johnson FL; Santana LF; Anderson ME; Song LS
    Circulation; 2014 Apr; 129(17):1742-50. PubMed ID: 24519927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistin deletion protects against heart failure injury by targeting DNA damage response.
    Zhao B; Bouchareb R; Lebeche D
    Cardiovasc Res; 2022 Jun; 118(8):1947-1963. PubMed ID: 34324657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Junctophilin-2 gene therapy rescues heart failure by normalizing RyR2-mediated Ca
    Reynolds JO; Quick AP; Wang Q; Beavers DL; Philippen LE; Showell J; Barreto-Torres G; Thuerauf DJ; Doroudgar S; Glembotski CC; Wehrens XH
    Int J Cardiol; 2016 Dec; 225():371-380. PubMed ID: 27760414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction.
    Abe I; Terabayashi T; Hanada K; Kondo H; Teshima Y; Ishii Y; Miyoshi M; Kira S; Saito S; Tsuchimochi H; Shirai M; Yufu K; Arakane M; Daa T; Thumkeo D; Narumiya S; Takahashi N; Ishizaki T
    Cardiovasc Res; 2021 Mar; 117(4):1103-1117. PubMed ID: 32647865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation and impact of cardiac lymphangiogenesis in pressure-overload-induced heart failure.
    Heron C; Dumesnil A; Houssari M; Renet S; Lemarcis T; Lebon A; Godefroy D; Schapman D; Henri O; Riou G; Nicol L; Henry JP; Valet M; Pieronne-Deperrois M; Ouvrard-Pascaud A; Hagerling R; Chiavelli H; Michel JB; Mulder P; Fraineau S; Richard V; Tardif V; Brakenhielm E
    Cardiovasc Res; 2023 Mar; 119(2):492-505. PubMed ID: 35689481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial-Specific Gene Delivery Using an Adeno-Associated Viral Vector.
    Ni L; Scott L; Campbell HM; Pan X; Alsina KM; Reynolds J; Philippen LE; Hulsurkar M; Lagor WR; Li N; Wehrens XHT
    Circ Res; 2019 Jan; 124(2):256-262. PubMed ID: 30582449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eicosapentaenoic acid suppresses adverse effects of C-reactive protein overexpression on pressure overload-induced cardiac remodeling.
    Nagai T; Anzai T; Mano Y; Kaneko H; Anzai A; Sugano Y; Maekawa Y; Takahashi T; Yoshikawa T; Fukuda K
    Heart Vessels; 2013 May; 28(3):404-11. PubMed ID: 22875408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calpain-2 specifically cleaves Junctophilin-2 at the same site as Calpain-1 but with less efficacy.
    Wang J; Ciampa G; Zheng D; Shi Q; Chen B; Abel ED; Peng T; Hall DD; Song LS
    Biochem J; 2021 Oct; 478(19):3539-3553. PubMed ID: 34524407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental model of congestive heart failure induced by transverse aortic constriction in BALB/c mice.
    Tannu S; Allocco J; Yarde M; Wong P; Ma X
    J Pharmacol Toxicol Methods; 2020; 106():106935. PubMed ID: 33096237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Load-Dependent Changes in Left Ventricular Structure and Function in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure.
    Weinheimer CJ; Kovacs A; Evans S; Matkovich SJ; Barger PM; Mann DL
    Circ Heart Fail; 2018 May; 11(5):e004351. PubMed ID: 29716898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AAV-mediated knock-down of HRC exacerbates transverse aorta constriction-induced heart failure.
    Park CS; Cha H; Kwon EJ; Jeong D; Hajjar RJ; Kranias EG; Cho C; Park WJ; Kim DH
    PLoS One; 2012; 7(8):e43282. PubMed ID: 22952658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting E3 Ubiquitin Ligase WWP1 Prevents Cardiac Hypertrophy Through Destabilizing DVL2 via Inhibition of K27-Linked Ubiquitination.
    Zhao D; Zhong G; Li J; Pan J; Zhao Y; Song H; Sun W; Jin X; Li Y; Du R; Nie J; Liu T; Zheng J; Jia Y; Liu Z; Liu W; Yuan X; Liu Z; Song J; Kan G; Li Y; Liu C; Gao X; Xing W; Chang YZ; Li Y; Ling S
    Circulation; 2021 Aug; 144(9):694-711. PubMed ID: 34139860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxiredoxin-1 ameliorates pressure overload-induced cardiac hypertrophy and fibrosis.
    Tang C; Yin G; Huang C; Wang H; Gao J; Luo J; Zhang Z; Wang J; Hong J; Chai X
    Biomed Pharmacother; 2020 Sep; 129():110357. PubMed ID: 32531679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.